|
-------------------------------------------------------------------------------------------------------------------
Optimization of Drug Formulations Using In Vitro-In Vivo
Modeling with STELLA® //
-------------------------------------------------------------------------------------------------------------------
Learn new techniques for
investigating possible bioavailability outcomes based on dissolution
study data
COURSE DESCRIPTION //
-------------------------------------
This course has been specifically designed to provide participants with
"hands on" applications of STELLA® in the optimization of in
vitro-in vivo relationships (dissolution-bioavailability
correlates) drug formulation development. STELLA® (isee Systems, Inc.) is a
powerful, graphic, object-based, model-building tool used to simulate
various systems and processes. Methods for generating and supporting
dissolution specifications, especially in the context of minor scale-up
and post-approval changes (SUPAC) as defined in recent FDA guidances,
will be thoroughly examined.
Although a comprehensive understanding of pharmacokinetic principles
(as per Kemic's "PHARMACOKINETICS: Essential
Theory ..." course) would be desirable, participants lacking
formal training in pharmacokinetics will still benefit from the
techniques and concepts presented in this course.
* Participants should supply their
own computer (PC or Mac) and are encouraged to bring
data from their specific R & D activities for analyses during the
course.
Participants will have the option to
separately purchase at a special discount price the STELLA®
software which will be provided for use during the course.
PARTIAL COURSE CONTENTS //
----------------------------------------------
- Introduction to STELLA® and use of numerical
techniques to simulate rate processes
- Review of pertinent pharmacokinetics
- Development of pharmacokinetic models in
STELLA® (single and multiple dose simulations)
- Optimization of dissolution profiles to obtain a
specific pharmacokinetic response prior to defining the in vitro-in
vivo relationship
- Estimation of bioavailability parameters from
dissolution profiles prior to defining an in vitro-in vivo
relationship
- Methods to evaluate the in vivo-in vitro
relationship
- Optimization of a formulation's dissolution profile
after establishing the in vitro- in vivo relationship
- Potential applications of STELLA® related to
SUPAC
PRINCIPAL INSTRUCTOR
> Arthur B. Straughn,
Pharm.D.
NOTE: Please contact us about arranging a special
in-house presentation to suit
your organization's specific requirements.
|
|